4Schiffman M, Solomon D. Clinical practice. Cervical cancer screening with human papillomavirus and cytologic cotesting [J]. N Engl J Med,2013,369(24) :2 324 -2 331.
5Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide bur- den of cancer in 2008 : GLOBOCAN 2008 : J ]. Int J Cancer, 2010,127(12) :2 893 -2 917.
7Herbert A, Bergeron C, Wiener H, et al. European guidelines for quality assurance in cervical cancer screening: recom- mendations for cervical cytology terminology[ J]. Cytopathol- ogy,2007,18 (4) :213 - 219.
8Haggar FA, Preen DB, Pereira G, et al. Cancer incidence and mortality trends in Australian adolescents and young a- dults, 1982 - 2007 [ J]. BMC Cancer,2012,12 : 151.
9Dickinson JA, Stankiewicz S, Popadiuk C, et al. Reduced cer- vical cancer incidence and mortality in Canada: national data from 1932 to 2006 [ J :. BMC Public Health ,2012,12:992.
10Castellsagu6 X, Pawlita M, Roura E, et al. Prospective sero- epidemiologie study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort [ J ]. Int J Cancer, 2013, 135 ( 2 ) : 440 - 452.
